WCLC 2025 - Posters & ePosters-P3.18.43 A Phase II Study of IDH1 Inhibitor Combined With Serplulimab and Docetaxel in Previously Treated Advanced NSCLC (ChiCTR2400086196)

P3.18.43 A Phase II Study of IDH1 Inhibitor Combined With Serplulimab and Docetaxel in Previously Treated Advanced NSCLC (ChiCTR2400086196)

Asset Subtitle

Shiji Zhang

Meta Tag

Speaker Shiji Zhang

Topic Clinical Trials in Progress